Presentation of the HPV16E7 protein by skin grafts is insufficient to allow graft rejection in an E7-primed animal

Virology

Volumn 235, Issue 1, 1997, Pages 94-103

  Dunn, Linda A ^a   Evander, Magnus ^a   Tindle, Robert W ^a   Bulloch, Anne Louise ^a   De Kluyver, Rachel L ^a   Fernando, Germain J P ^a   Lambert, Paul F ^b   Frazer, Ian H ^a  

^a UNIVERSITY OF QUEENSLAND   (Australia)

^b UNIVERSITY OF WISCONSIN MADISON   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

VIRUS PROTEIN;

ANIMAL CELL; ANIMAL TISSUE; ANTIGEN SPECIFICITY; ARTICLE; CELL TRANSFORMATION; DIAGNOSIS; GRAFT REJECTION; MOUSE; NONHUMAN; OPEN READING FRAME; PRIORITY JOURNAL; SKIN GRAFT; TUMOR IMMUNOLOGY; WART VIRUS;

ANIMALIA; HUMAN PAPILLOMAVIRUS; HUMAN PAPILLOMAVIRUS TYPE 16; HUMAN PAPILLOMAVIRUS TYPES;

EID: 0030796281     PISSN: 00426822     EISSN: None     Source Type: Journal    
DOI: 10.1006/viro.1997.8650     Document Type: Article

References (40)

1. Andersson E. C., Christensen J. P., Marker O., Thomsen A. R. Changes in cell adhesion molecule expression on T cells associated with systemic virus infection. J. Immunol. 152:1994;1237-1245.
2. Antoniou A., McCormick D., Scott D., Yeoman H., Chandler P., Mellor A., Dyson J. T cell tolerance and activation to a transgene-encoded tumour antigen. Eur. J. Immunol. 26:1996;1094-1102.
3. Auewarakul P., Gissmann L., Cid-Arregui A. Targeted expression of the E6 and E7 oncogenes of human papillomavirus type 16 in the epidermis of transgenic mice elicits generalized epidermal hyperplasia involving autocrine factors. Mol. Cell. Biol. 14:1994;8250-8258.
4. Bailey D. W., Usama B. A rapid method of grafting skin on tails of mice. Transplant. Bull. 25:1960;424-425.
5. Cairns B. A., DeSerres S., Matsui M., Frelinger J. A., Meyer A. A. Cultured mouse keratinocyte allografts prime for accelerated second set rejection and enhanced cytotoxic lymphocyte response. Transplantation. 58:1994;67-72.
6. Chen L., Mizuno M. T., Singhal M. C., Hu S.-L., Galloway D. A., Hellström I., Hellström K. E. Induction of cytotoxic T lymphocytes specific for a syngeneic tumor expressing the E6 oncoprotein of human papillomavirus type 16. J. Immunol. 148:1992;2617-2621.
7. Comerford S. A., McCance D. J., Dougan G., Tite J. P. Identification of T- and B-cell epitopes of the E7 protein of human papillomavirus type 16. J. Virol. 65:1991;4681-4690.
8. Dumois J. A., VanderVegt F. P., Kopp J. B., Marinos N. J., Rooney J. F., Notkins A. L. Transplantation of skin from human immunodeficiency virus type 1-transgenic mice to normal congenic mice results in graft rejection. J. Infect. Dis. 172:1995;232-234.
9. Enk A. H., Katz S. I. Early molecular events in the induction phase of contact sensitivity. Proc. Natl. Acad. Sci. USA. 89:1992;1398-1402.
10. Feltkamp M. C. W., Smits H. L., Vierboom M. P. M., Minnaar R. P., De Jongh B. M., Wouter Drijfhout J., Ter Schegget J., Melief C. J. M., Kast W. M. Vaccination with cytotoxic T lymphocyte epitope-containing peptide protects against a tumor induced by human papillomavirus type 16-transformed cells. Eur. J. Immunol. 23:1993;2242-2249.
11. Frazer I. H., Leippe D. M., Dunn L. A., Liem A., Tindle R. W., Fernando G. J. P., Phelps W. C., Lambert P. F. Immunological responses in human papillomavirus 16 E6/E7-transgenic mice to E7 protein correlate with the presence of skin disease. Cancer Res. 55:1995;2635-2639.
12. Garrigue J. L., Nicolas J. F., Fraginals R., Benezra C., Bour H., Schmitt D. Optimization of the mouse ear swelling test for in vivo and in vitro studies of weak contact sensitizers. Contact. Dermatitis. 30:1994;231-237.
13. Graff R. J., Snell G. D. Histocompatibility typing of inbred mice for known non-H-2 alleles. Transplant. Proc. 1:1969;362-364.
14. Griep A. E., Herber R., Jeon S., Lohse J. K., Dubielzig R. R., Lambert P. F. Tumorigenicity by human papillomavirus type 16 E6 and E7 in transgenic mice correlates with alterations in epithelial cell growth and differentiation. J. Virol. 67:1993;1373-1384.
15. Hammond E. J., Ng R. L., Stanley M. A., Munro A. J. Prolonged survival of cultured keratinocyte allografts in the nonimmunosuppressed mouse. Transplantation. 44:1987;106-112.
16. Herber R., Liem A., Pitot H., Lambert P. F. Squamous epithelial hyperplasia and carcinoma in mice transgenic for the human papillomavirus type 16 E7 oncogene. J. Virol. 70:1996;1873-1881.
17. Jochmus-Kudielka I., Schneider A., Braun R., Kimmig R., Koldovsky U., Schneweis K. E., Seedorf K., Gissmann L. Antibodies against the human papillomavirus type 16 early proteins in human sera: Correlation of anti-E7 reactivity with cervical cancer. JNCI. 81:1989;1698-1704.
18. Juretic A., Knowles B. B. SV40 T antigen acts as a minor histocompatibility antigen of SV40 T antigen tolerant transgenic mice. Immunogenetics. 29:1989;366-370.
19. Kawai K., Ikarashi Y., Tomiyama K., Matsumoto Y., Fujiwara M. Rejection of cultured keratinocyte allografts in presensitized mice. Transplantation. 56:1993;265-269.
20. Kim D. T., Rothbard J. B., Bloom D. D., Fathman C. G. Quantitative analysis of T cell activation. J. Immunol. 156:1996;2737-2742.
21. Kondoh G., Murata Y., Aozasa K., Yutsudo M., Hakura A. Very high incidence of germ cell tumorigenesis (seminomagenesis) in human papillomavirus type 16 transgenic mice. J. Virol. 65:1991;3335-3339.
22. Kruisbeek A. M., Amsen D. Mechanisms underlying T-cell tolerance. Curr. Opin. Immunol. 8:1996;233-244.
23. Lambert P. F., Pan H., Pitot H., Liem A., Jackson M., Griep A. E. Epidermal cancer associated with expression of human papillomavirus type 16 E6 and E7 oncogenes in the skin of transgenic mice. Proc. Natl. Acad. Sci. USA. 90:1993;5583-5587.
24. Mayumi H., Nomoto K., Good R. A. A surgical technique for experimental free skin grafting in mice. Jpn. J. Surg. 18:1988;548-557.
25. McLean C. S., Sterling J. S., Mowat J., Nash A. A., Stanley M. A. Delayed-type hypersensitivity response to the human papillomavirus type 16 E7 protein in a mouse model. J. Gen. Virol. 74:1993;239-245.
26. Nickoloff B. J., Turka L. A., Mitra R. S., Nestle F. O. Direct and indirect control of T-cell activation by keratinocytes. J. Invest. Dermatol. 105:1995;25S-29S.
27. Rosenberg A. S., Katz S. I., Singer A. Rejection of skin allografts by CD4+ T cells is antigen-specific and requires expression of target alloantigen on Ia-epidermal cells. J. Immunol. 143:1989;2452-2456.
28. Sasagawa T., Kondoh G., Inoue M., Yutsudo M., Hakura A. Cervical/vaginal dysplasias of transgenic mice harbouring human papillomavirus type 16 E6-E7 genes. J. Gen. Virol. 75:1994;3057-3065.
29. Selvey L. A., Dunn L. A., Murray B., Tindle R. W., Frazer I. H. An ELISA capture assay for the E7 transforming proteins of HPV16 and HPV18. J. Virol. Methods. 37:1992;119-128.
30. Selvey L. A., Dunn L. A., Tindle R. W., Park D. S., Frazer I. H. Human papillomavirus (HPV) type 18 E7 protein is a short-lived steroid-inducible phosphoprotein in HPV-transformed cell lines. J. Gen. Virol. 75:1994;1647-1653.
31. Scott D. M., Ehrmann I. E., Ellis P. S., Bishop C. E., Agulnik A. I., Simpson E., Mitchell M. J. Identification of a mouse male-specific transplantation antigen, H-Y. Nature. 376:1995;695-698.
32. Symington F. W., Santos E. B. Lysis of human keratinocytes by allogeneic HLA class I-specific cytotoxic T cells: Keratinocyte ICAM-1 (CD54) and T cell LFA-1 (CD11a/CD18) mediate enhanced lysis of IFN-gamma-treated keratinocytes. J. Immunol. 146:1991;2169-2175.
33. Tindle R. W., Smith J. A., Geysen H. M., Selvey L. A., Frazer I. H. Identification of B epitopes in human papillomavirus type 16 E7 open reading frame protein. J. Gen. Virol. 71:1990;1347-1354.
34. Tindle R. W., Fernando G. J. P., Sterling J. C., Frazer I. H. A "public" T-helper epitope of the E7 transforming protein of human papillomavirus 16 provides cognate help for several E7 B-cell epitopes from cervical cancer-associated human papillomavirus genotypes. Proc. Natl. Acad. Sci. USA. 88:1991;5887-5891.
35. Tindle R. W., Croft S., Herd K., Malcolm K., Geczy A. F., Stewart T., Fernando G. J. P. A vaccine conjugate of 'ISCAR' immunocarrier and peptide epitopes of the E7 cervical cancer-associated protein of human papillomavirus type 16 elicits specific Th1- and Th2-type responses in immunized mice in the absence of oil-based adjuvants. Clin. Exp. Immunol. 101:1995;265-271.
36. Tinois E., Cobbold S., Faure M., Yeoman H., Stanley M. Cultured keratinocyte grafts are recognized, but not rejected by CD8+ T cells in vivo. Eur. J. Immunol. 19:1989;1031-1035.
37. Wettstein P. J., Colombo M. P., Jaenisch R. Non-H-2 histocompatibility antigens encoded by Moloney Murine leukemia virus in Mov mouse strains are detectable by skin grafting and cytolytic T lymphocytes. J. Immunol. 140:1988a;4337-4341.
38. Wettstein P. J., Jewett L., Faas S., Brinster R. L., Knowles B. B. SV40 T-antigen is a histocompatibility antigen of SV40-transgenic mice. Immunogenetics. 27:1988b;436-441.
39. Yamamoto N., Zou J. P., Li X. F., Takenaka H., Noda S., Fujii T., Ono S., Kobayashi Y., Mukaida N., Matsushima K. Regulatory mechanisms for production of IFN-gamma and TNF by antitumor T cells or macrophages in the tumor-bearing state. J. Immunol. 154:1995;2281-2290.
40. Zur Hausen H. Human papillomaviruses in the pathogenesis of anogenital cancer. Virology. 184:1991;9-13.